HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer
Open Access
- 1 September 2002
- journal article
- research article
- Published by Elsevier BV in Annals of Oncology
- Vol. 13 (9), 1398-1403
- https://doi.org/10.1093/annonc/mdf217
Abstract
Background: The HER-2/neu gene is amplified in 20–30% of human breast cancers and has been shown to have prognostic and predictive value for treatment with chemotherapy, hormone therapy and antibodies against the HER-2/neu domain (trastuzumab). The aim of our study was to evaluate the reliability of HER-2/neu determination by fluorescence in situ hybridization (FISH) on fine-needle aspirates (FNAs) from primary breast cancer patients by comparison with the results obtained by FISH and immunohistochemistry (IHC) on the corresponding histological sections. Materials and methods: HER-2/neu amplification was determined by FISH on 66 breast cancer FNAs. Twenty-three and 36 corresponding formalin-fixed, paraffin-embedded sections were assayed by FISH and by IHC, respectively, in order to detect HER-2/neu amplification and HER-2/neu protein expression. Results: Twenty-seven per cent (18/66) of breast cancer FNAs showed amplification of HER-2/neu by FISH. Paired results by FISH cytology and FISH histology were available in 22 cases. Concordance was 91% (20/22). Paired results by FISH cytology and IHC were available in 36 cases. Concordance was 92% (33/36). Eighteen of 66 breast cancer FNAs were also submitted to flow cytometric DNA analysis. None of the diploid cases showed HER-2/neu amplification by FISH. Six out of the eight aneuploid cases were amplified and two were polysomic. Conclusions: HER-2/neu gene amplification can be reliably estimated by FISH on breast cancer FNAs and a good correlation has been found between FISH and IHC results from the corresponding histological sections.Keywords
This publication has 6 references indexed in Scilit:
- Patterns of HER-2/neu Amplification and Overexpression in Primary and Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 2001
- Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis ofHER-2/neu gene amplification in breast cancer fine-needle samplesCancer, 1999
- c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspiratesBritish Journal of Cancer, 1999
- Fluorescence in situ hybridisation detection of erbB2 amplification in breast cancer fine needle aspiratesMolecular Pathology, 1999
- ERBB2 oncogene in human breast cancer and its clinical significanceEuropean Journal of Cancer, 1998
- Fluorescence in Situ Hybridization for Detecting ErbB-2 Amplification in Breast Tumor Fine Needle Aspiration BiopsiesActa Cytologica, 1996